Roivant Sciences Ltd. Share Price
NASDAQ: ROIV | Large CapRoivant Sciences Ltd. Stock Performance
Roivant Sciences Ltd. Share Price Today
As of 30 October 2026, Roivant Sciences Ltd.'s share price is $37.50. The stock opened at $37.48, compared to its previous close of $37.12. During today's trading session, Roivant Sciences Ltd.'s share price traded between $37.29 and $37.96, with an average price of $37.63. Over the past 52 weeks, the stock has recorded a high of $42.49 and a low of $18.35. In terms of performance, Roivant Sciences Ltd.'s share price has risen by 31.44% over the last six months and is up 87.64% on a year-on-year basis.
Roivant Sciences Ltd. Share Price Chart
Roivant Sciences Ltd. Quarterly Profit & Loss
All figures in USD
Roivant Sciences Ltd. Annual Profit & Loss
All figures in USD
About Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
Roivant Sciences Ltd. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $36.24 | $37.52 | +2.49% |
Sep 2026 | $34.63 | $36.61 | -2.56% |
Aug 2026 | $33.18 | $37.57 | +10.81% |
Jul 2026 | $35.33 | $33.91 | -4.22% |
Jun 2026 | $29.36 | $35.40 | +17.98% |
May 2026 | $28.75 | $30.00 | +5.17% |
Apr 2026 | $28.05 | $28.53 | +2.96% |
Mar 2026 | $28.64 | $27.71 | -4.27% |
Feb 2026 | $21.48 | $28.95 | +33.94% |
Jan 2026 | $21.67 | $21.61 | -0.37% |
Dec 2025 | $20.55 | $21.69 | +4.18% |
Nov 2025 | $19.93 | $20.82 | +4.18% |